Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study
The aim of the study was to evaluate the characteristics of chronic hepatitis B with special reference to the geographical origin of the patients and to the prevalence of HBeAg and viral and non-viral co-factors of liver disease. A cross-sectional multicenter survey was undertaken, which enrolled 1,...
Saved in:
Published in | Journal of medical virology Vol. 81; no. 12; pp. 1999 - 2006 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.12.2009
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The aim of the study was to evaluate the characteristics of chronic hepatitis B with special reference to the geographical origin of the patients and to the prevalence of HBeAg and viral and non-viral co-factors of liver disease. A cross-sectional multicenter survey was undertaken, which enrolled 1,386 HBsAg chronic carriers observed consecutively in 21 referral centers over a 6-month period. The prevalence of HBeAg in patients was 11%; the presence of HBeAg was associated independently with a younger age and co-infection with HIV. Anti-HDV, anti-HCV, or anti-HIV antibodies were detected in 8.1%, 6.5%, and 2%, respectively. However, among the patients first diagnosed during the study period (incident cases), 14.3% were anti-HDV positive. Seven percent of the patients were immigrants; they were younger than Italian patients and 18% were HBeAg positive; no difference was observed in the prevalence of anti-HDV, anti-HCV, or anti-HIV antibodies. The presence of cirrhosis was associated independently with an age >52 years, the presence of anti-HDV or anti-HCV, alcohol use >4 drinks/day, and a high BMI. The clinical epidemiology of chronic hepatitis B virus (HBV) infection shows a dynamic profile, with the potential for re-emergence of cases with HBeAg or anti-HDV and an emerging impact of metabolic factors on the evolution of liver disease. J. Med. Virol. 81:1999-2006, 2009. |
---|---|
Bibliography: | http://dx.doi.org/10.1002/jmv.21643 ArticleID:JMV21643 ark:/67375/WNG-97S1V78G-R istex:A2A7D95FBB928ADBFDDFCB7FC56315EA1270E34F Pietro Andreone, Alessandra Scuteri, Internal Medicine, University of Bologna; Giorgio Antonucci, Fabio Iacomi, INMI Spallanzani, Rome; Sergio Babudieri, Antonio Pintus, Infectious Diseases, University of Sassari; Gianfranca Stornaiuolo, Giuseppina Brancaccio, Viral Hepatitis Unit, Second University, Naples; Maurizia Brunetto, Rodolfo Sasso, Gastroenterology and Hepatology, Pisa; Nicola Caporaso, Filomena Morisco, Gastroenterology, University Federico II, Naples; Maria Chiaramonte, Emiliano Lattanzi, Gastroenterology, L'Aquila; Vito Di Marco, Giovanna Venezia, Gastroenterology, University of Palermo; Stefano Fagiuoli, Sara Boninsegna, Gastroenterology, Bergamo; Giovanna Fattovich, Nicola Olivari, Gastroenterology, University of Verona; Carlo Ferrari, Tiziana Giuberti, Infectious Diseases, Parma; Luigina Ferrigno, Clinical Epidemiology Unit, Istituto Superiore di Sanità, Rome; Giacomo Magnani, Marco Massari, Infectious Diseases, Novara; Carmelo Mangano, Carmelo Caserta, Internal Medicine, Reggio Calabria; Vincenzo Messina, Infectious Diseases, Caserta; Giuseppe Pastore, Stefania Palattella, Infectious Diseaases, University of Bari; Felice Piccinino, Maria Stanzione, Infectious Diseases, Second University of Naples; Giovanbattista Pinzello, Maria Vinci, Hepatology and Gastroenterology, Milan; Giovanni Raimondo, Gaia Caccamo, Clinical and Molecular Hepatology, University of Messina; Luigi Roffi, Valentina Bellia, Internal Medicine, Sondrio; Mario Rizzetto, Antonina Smedile, Alessia Ciancio, Gastroenterology, University of Turin. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0146-6615 1096-9071 |
DOI: | 10.1002/jmv.21643 |